Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Cecilie D Browne
Introduction
Cecilie D Browne is a notable inventor based in Reston, Virginia. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic peptides. Her work focuses on enhancing cellular immunity through innovative approaches.
Latest Patents
Cecilie D Browne holds a patent for LAG3 binding peptides. This patent discloses peptides that bind to LAG3, which can block its interaction with other molecules such as MHC-II, FGL1, and α-synuclein. These peptides demonstrate activity and a short half-life, making them suitable for activating cellular immunity while minimizing the adverse events often associated with antibody-based checkpoint inhibitors. The peptides can be utilized as stand-alone therapeutics or as immune modulators in combination with other therapies.
Career Highlights
Cecilie D Browne is currently employed at Leidos, Inc., where she continues to advance her research and development efforts. Her innovative work has positioned her as a key figure in her field, contributing to the understanding and application of immune modulation.
Collaborations
Cecilie has collaborated with notable colleagues, including Gabriel M Gutierrez and James Pannucci. These collaborations have further enriched her research and expanded the impact of her inventions.
Conclusion
Cecilie D Browne's contributions to biotechnology through her innovative patent on LAG3 binding peptides highlight her role as a leading inventor in her field. Her work not only advances scientific knowledge but also has the potential to improve therapeutic strategies in medicine.